Incyte Corp

Common Name

Incyte

Country

United States

Sector

Healthcare

Industry

Biotechnology

Employees

2,617

Ticker

INCY

Exchange

NASDAQ/NGS

Website

www.incyte.com

Description

Incyte Corporation is a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapeutics. With a focus on oncology and inflammation, Incyte aims to a... Show more

Income Statement Balance Sheet Group Entities

Incyte's Financial Statements Preview

Below are the financial statements of Incyte, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?

Learn More

Limited Data Preview

You are viewing a limited preview of Incyte’s balance sheet data. The reported financial values are complete. The full dataset, available for download, additionally includes structured metadata for each line item, such as line item role (line item, subtotal, total) and financial classification (e.g., assets, liabilities, equity, revenue, expenses).

Unrestricted Access to Data and Sources

pro

Remove manual data sourcing from your workflow. Upgrade to Tracenable Pro for unrestricted access to datasets and disclosures across 8,500+ companies with over 10 years of historical coverage.

Download complete datasets (CSV/XLS)

Access underlying corporate disclosures (PDF)

Trace values back to original sources

Upgrade to Tracenable Pro

Formats Included

Excel

CSV

All data fully traceable to original sources

Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Incyte’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Incyte’s data sources below and access millions more through our Disclosure Search.

a. Incyte's 10-K 2024

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

All figures in millions of USD	2024 as of 2024-12-31	2023 as of 2023-12-31
Assets	—	—
Current assets	—	—
Cash and cash equivalents	1,687.83^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	3,213.38^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up
Marketable securities - available-for-sale	470.26^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	442.67^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up
Accounts receivable	853.15^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	743.56^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up
Inventory	58.87^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	62.97^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up
Prepaid expenses and other current assets	168.91^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	182.83^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up
Total current assets	3,239.03^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	4,645.4^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up
Restricted cash	1.62^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	1.85^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up
Long term equity investments	18.81^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	187.72^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up
Inventory	348.33^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	206.97^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up
Property and equipment, net	763.41^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	751.51^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up
Finance lease right-of-use assets, net	30.8^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	25.54^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up
Other intangible assets, net	113.8^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	123.55^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up
Goodwill	155.59^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	155.59^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up
Deferred income tax asset	762.07^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	631.89^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up
Other assets, net	10.85^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	52.11^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up
Total assets	5,444.32^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	6,782.11^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up
Liabilities and stockholders’ equity	—	—
Current liabilities	—	—
Accounts payable	197.47^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	109.6^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up
Accrued compensation	188.68^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	153.35^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up
Accrued and other current liabilities	1,212.05^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	935.57^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up
Finance lease liabilities	4.42^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	3.44^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up
Acquisition-related contingent consideration	39.24^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	38.42^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up
Total current liabilities	1,641.85^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	1,240.38^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up
Acquisition-related contingent consideration	153.76^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	173.58^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up
Finance lease liabilities	33.54^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	29.16^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up
Other liabilities	167.54^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	149.15^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up
Total liabilities	1,996.69^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	1,592.27^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up
Stockholders’ equity	—	—
Preferred stock, $0.001 par value	0^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	0^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up
Common stock, $0.001 par value	0.19^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	0.22^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up
Additional paid-in capital	4,533.44^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	5,016.12^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up
Accumulated other comprehensive (loss) income	-13.12^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	13.11^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up
(Accumulated deficit) retained earnings	-1,072.88^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	160.39^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up
Total stockholders’ equity	3,447.63^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	5,189.84^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up
Total liabilities and stockholders’ equity	5,444.32^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	6,782.11^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up

Incyte Corp

Incyte's Financial Statements Preview

Incyte's Financial Statements Preview

Verified Sources Behind Incyte’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Royalty Pharma PLC

Revolution Medicines Inc

Insmed Inc

Madrigal Pharmaceuticals Inc

Ultragenyx Pharmaceutical Inc

Cytokinetics Inc